Revenue: The sum of all revenue fields included for a company's operating activities.
Vertex Pharmaceuticals Incorporated (VRTX) had Revenue of $9.87B for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$9.87B |
$3.62B |
|
$1.26B |
|
$8.61B |
|
$6.04B |
|
$3.83B |
|
$547.80M |
|
$4.38B |
|
$4.38B |
|
$3.62B |
|
$3.62B |
|
$3.62B |
|
$3.62B |
|
$3.83B |
|
$4.01B |
|
257.70M |
|
260.50M |
|
$14.05 |
|
$13.89 |
|
| Balance Sheet Financials | |
$14.14B |
|
$1.16B |
|
$8.59B |
|
$22.73B |
|
$3.55B |
|
$376.10M |
|
$1.60B |
|
$5.15B |
|
$17.58B |
|
$15.65B |
|
$17.58B |
|
257.69M |
|
| Cash Flow Statement Financials | |
$3.54B |
|
$-3.14B |
|
$-562.20M |
|
$10.51B |
|
$10.37B |
|
$-139.70M |
|
$581.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
87.21% |
|
38.83% |
|
38.83% |
|
40.66% |
|
44.38% |
|
36.68% |
|
$3.34B |
|
-- |
|
-- |
|
-- |
|
0.43 |
|
1.71 |
|
6.31 |
|
57.82 |
|
20.59% |
|
23.12% |
|
15.92% |
|
20.16% |
|
$68.22 |
|
$12.81 |
|
$13.58 |
|